PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21327800-0	2011	Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen.	Tamoxifen	131-140	progesterone receptor	Homo sapiens	25-46	
21327800-10	2011	CONCLUSIONS: In ER-positive, operable breast cancer, PR negativity may provide additional information on poor prognosis or tamoxifen resistance during adjuvant tamoxifen therapy within 5 years postsurgery.	Tamoxifen	123-132	progesterone receptor	Homo sapiens	53-55	
21327800-10	2011	CONCLUSIONS: In ER-positive, operable breast cancer, PR negativity may provide additional information on poor prognosis or tamoxifen resistance during adjuvant tamoxifen therapy within 5 years postsurgery.	Tamoxifen	160-169	progesterone receptor	Homo sapiens	53-55